Cetera Advisor Networks’s Nektar Therapeutics NKTR Stock Holding History

Cetera Advisor Networks’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$11.3K	Buy	+809	New	+$8.47K	﹤0.01%	2795
2020 Q3	–	Sell	-355	Closed	-$123K	–	2390
2020 Q2	$123K	Buy	+355	New	+$111K	﹤0.01%	1383
2019 Q3	–	Sell	-603	Closed	-$325K	–	1226
2019 Q2	$325K	Sell	603 -10	-2%	-$5.01K	0.01%	878
2019 Q1	$314K	Sell	613 -12	-2%	-$7.11K	0.01%	848
2018 Q4	$312K	Buy	625 +34	+6%	+$20.5K	0.01%	743
2018 Q3	$535K	Buy	591 +243	+70%	+$207K	0.02%	610
2018 Q2	$258K	Buy	348 +68	+24%	+$78.4K	0.01%	692
2018 Q1	$449K	Buy	+280	New	+$361K	0.02%	530

Other funds holding NKTR

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Advisor Networks's NKTR Position: Q1 2024 in Review

Cetera Advisor Networks opened a new position in Nektar Therapeutics (NKTR) in Q1 2024: 809 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #2795 among its holdings. This is a return to the name: Cetera Advisor Networks previously reported a position in NKTR as recently as Q2 2020.

Cetera Advisor Networks first reported a position in NKTR in Q1 2018 and has held it in 8 quarters since. The position peaked at $535K in Q3 2018. 124 funds tracked by Wall St. Rank hold NKTR as of Q1 2024.

Cetera Advisor Networks held 809 shares of Nektar Therapeutics worth $11.3K as of Q1 2024.
Nektar Therapeutics was a new Cetera Advisor Networks position in Q1 2024.
Nektar Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2795 holding.
Cetera Advisor Networks first reported a position in Nektar Therapeutics in Q1 2018 and has held it in 8 quarters since.
Cetera Advisor Networks's Nektar Therapeutics position peaked at $535K in Q3 2018.
124 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.